Literature DB >> 6500367

Delta agent infection in acute hepatitis and chronic HBsAg carriers with and without liver disease.

A Craxì, G Raimondo, G Longo, G Giannuoli, R De Pasquale, M Caltagirone, S Patti, G Squadrito, L Pagliaro.   

Abstract

Hepatitis B virus (HBV) is a major cause of chronic liver disease in southern Italy. In the same area superinfection with the delta agent is endemic. To assess the prevalence of delta infection in a large population of patients with acute and chronic HBV related liver disease and to look for differential features among delta infected and uninfected subjects sera from 592 consecutive HBsAg positive patients were tested for the delta/anti-delta system by RIA. In no case was delta Ag found in serum. The prevalence of anti-delta was low in acute hepatitis (6.6%) and in asymptomatic carriers (6.4%) but raised in chronic active hepatitis with or without cirrhosis (52.3%). A decrease in frequency of anti-delta was seen in inactive cirrhosis (38.8%) and in hepatocellular carcinoma (11.9%). A younger mean age of delta-infected subjects was observed in each type of chronic liver disease. Our data confirm that delta agent superinfection is definitely associated with severe chronic active liver disease. The difference in age between anti-delta positive and negative patients suggests that delta infection accelerates the natural history of HBV related liver disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6500367      PMCID: PMC1432324          DOI: 10.1136/gut.25.11.1288

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  11 in total

1.  Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers.

Authors:  M Rizzetto; R H Purcell; J L Gerin
Journal:  Lancet       Date:  1980-06-07       Impact factor: 79.321

2.  Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers.

Authors:  M Rizzetto; M G Canese; S Aricò; O Crivelli; C Trepo; F Bonino; G Verme
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

3.  Infection with the delta agent in chronic HBsAg carriers.

Authors:  A Smedile; P Dentico; A Zanetti; E Sagnelli; E Nordenfelt; G C Actis; M Rizzetto
Journal:  Gastroenterology       Date:  1981-12       Impact factor: 22.682

4.  Incidence and significance of antibodies to delta antigen in hepatitis B virus infection.

Authors:  M Rizzetto; J W Shih; D J Gocke; R H Purcell; G Verme; J L Gerin
Journal:  Lancet       Date:  1979-11-10       Impact factor: 79.321

5.  Influence of delta infection on severity of hepatitis B.

Authors:  A Smedile; P Farci; G Verme; F Caredda; A Cargnel; N Caporaso; P Dentico; C Trepo; P Opolon; A Gimson; D Vergani; R Williams; M Rizzetto
Journal:  Lancet       Date:  1982-10-30       Impact factor: 79.321

6.  Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts.

Authors:  G Raimondo; A Smedile; L Gallo; A Balbo; A Ponzetto; M Rizzetto
Journal:  Lancet       Date:  1982-01-30       Impact factor: 79.321

7.  Epidemiologic patterns of infection with the hepatitis B virus-associated delta agent in Italy.

Authors:  A Smedile; C Lavarini; P Farci; S Aricò; G Marinucci; P Dentico; G Giuliani; A Cargnel; C Del Vecchio Blanco; M Rizzetto
Journal:  Am J Epidemiol       Date:  1983-02       Impact factor: 4.897

8.  The hepatitis B virus-associated delta antigen: isolation from liver, development of solid-phase radioimmunoassays for delta antigen and anti-delta and partial characterization of delta antigen.

Authors:  M Rizzetto; J W Shih; J L Gerin
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

9.  Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment.

Authors:  M Rizzetto; G Verme; S Recchia; F Bonino; P Farci; S Aricò; R Calzia; A Picciotto; M Colombo; H Popper
Journal:  Ann Intern Med       Date:  1983-04       Impact factor: 25.391

10.  delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees.

Authors:  M Rizzetto; B Hoyer; M G Canese; J W Shih; R H Purcell; J L Gerin
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

View more
  8 in total

1.  Hepatitis delta infections.

Authors:  K G Nicholson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-11

2.  Kinetics of delta antigen and delta antibody in acute delta hepatitis: evaluation with different enzyme immunoassays.

Authors:  F Dubois; A Goudeau
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

3.  A study on delta virus infection and its clinical impact in Iran.

Authors:  H Rezvan; B Forouzandeh; S Taroyan; S Fadaiee; F Azordegan
Journal:  Infection       Date:  1990 Jan-Feb       Impact factor: 3.553

4.  Hepatitis D virus infection, replication and cross-talk with the hepatitis B virus.

Authors:  Chi-Ruei Huang; Szecheng John Lo
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 5.  Delta hepatitis: molecular biology and clinical and epidemiological features.

Authors:  L B Polish; M Gallagher; H A Fields; S C Hadler
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

Review 6.  Delta and non-A, non-B hepatitis viruses.

Authors:  F Bonino; M Baldi; A Demartini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267

7.  Hepatitis B-DNA replication and histological patterns in liver biopsy specimens of chronic HBsAg positive patients with and without hepatitis delta virus superinfection.

Authors:  D Villari; G Raimondo; V Smedile; G Rodinó; S Brancatelli; G Longo; G Squadrito; D Batolo
Journal:  J Clin Pathol       Date:  1989-07       Impact factor: 3.411

8.  Prevalence and significance of intrahepatic hepatitis delta virus antigen expression in HBeAg-negative patients with chronic type-B hepatitis in Taiwan.

Authors:  C M Chu; W C Shyu; Y F Liaw
Journal:  Dig Dis Sci       Date:  1989-12       Impact factor: 3.199

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.